DexCom reported strong Q4 results and record new patients. The company expects continued growth in 2025, focusing on expanding coverage and market share. The introduction of the 15-day sensor and Stelo are key drivers. Sustainability of international growth and profitability improvements are also on the agenda.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay